NDC 76420-217 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC76420-217

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Asclemed USA, Inc.
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (5)

Package NDCDescriptionSince
76420-217-044 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-04)Jul 20, 2022
76420-217-066 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-06)Jul 20, 2022
76420-217-1010 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-10)Jul 20, 2022
76420-217-2020 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-20)Jul 20, 2022
76420-217-303 BLISTER PACK in 1 CARTON (76420-217-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKJul 20, 2022

Other Ondansetron products